Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00162812
Status:
TERMINATED
Last Update Posted:
2008-07-18
First Post:
2005-09-09
Brief Title:
Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin
Sponsor:
Jules Bordet Institute
Organization:
Jules Bordet Institute
Organization Data
Organization:
Jules Bordet Institute
Class:
OTHER
Study ID:
TOP Trial
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jules Bordet Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Veronique DHondt
Old Organization:
Jules Bordet Institute
Collaborators
| Name | Class |
|---|---|
| Feculdade de Medicina da Universidade de Sao Paulo - Brasil | OTHER |
| Gustave Roussy Cancer Campus Grand Paris | OTHER |
| Centre Paul Strauss | OTHER |
| Centre Hospitalier du Luxembourg | OTHER |
| Clinique Louis Cathy - Baudour - Belgium | UNKNOWN |
| HIS - Site Etterbeek - Ixelles - Belgium | UNKNOWN |
| Clinique Saint Pierre Ottignies | OTHER |
| Clinique Ste Elisabeth - Namur - Belgium | UNKNOWN |
| University Hospital of Crete | OTHER |